FDA “Ministerial” Approach To Patent Listings Upheld By Appeals Court
This article was originally published in The Tan Sheet
Executive Summary
An appeals court's dismissal of Apotex' lawsuit against FDA relating to patent listings affirms a key provision in the final rule reforming Hatch/Waxman